Evidence map›Paper›PMID 29739946›Full record

ArticleNature communications2018

NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells.

Gene I Uenishi, Ho Sun Jung, Akhilesh Kumar, Mi Ae Park, Brandon K Hadland, Ethan McLeod, Matthew Raymond, Oleg Moskvin, Catherine E Zimmerman, Derek J Theisen and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. ABlood vessels, thrombosis & hemostasis · 2025
    Article
  10. Towards advanced regenerative therapeutics to tackle cardio-cerebrovascular diseases.American heart journal plus : cardiology research and practice · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. NMolecular medicine (Cambridge, Mass.) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Gene I UenishiWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.
Ho Sun JungWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.
Akhilesh KumarWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.ORCID http://orcid.org/0000-0003-2757-5181
Mi Ae ParkWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.ORCID http://orcid.org/0000-0002-7601-5976
Brandon K HadlandDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA, 98109, USA.
Ethan McLeodWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.
Matthew RaymondWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.
Oleg MoskvinWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.ORCID http://orcid.org/0000-0003-1499-8900
Catherine E ZimmermanWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.
Derek J TheisenWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA.ORCID http://orcid.org/0000-0002-2204-8676
Scott SwansonMorgridge Institute for Research, Madison, WI, 53715, USA.ORCID http://orcid.org/0000-0002-3314-0515
Owen J TamplinDepartment of Pharmacology, University of Illinois, Chicago, IL, 60612, USA.ORCID http://orcid.org/0000-0001-9146-4860
Leonard I ZonStem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0003-0860-926X
James A ThomsonMorgridge Institute for Research, Madison, WI, 53715, USA.
Irwin D BernsteinDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA, 98109, USA.
Igor I SlukvinWisconsin National Primate Research Center, University of Wisconsin, Madison, WI, 53715, USA. islukvin@wisc.edu.ORCID http://orcid.org/0000-0001-9693-6927
University of Wisconsin–Madison · USUniversity of Washington · USHoward Hughes Medical Institute · USMorgridge Institute for Research · USUniversity of Illinois Chicago · US

Funding

WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Kai W Wucherpfennig · 2013 to 2026
$25.3M
Transcriptional and epigenetic heterogeneity of stem/progenitor cellsP01HL131477 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI David T Scadden · 2017 to 2026
$24.6M
Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Stem cells for therapeutics discovery in genetic blood disordersU01HL134812 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q, LIPTON, JEFFREY M · 2016 to 2022
$8.3M
Midwest Progenitor Cell ConsortiumU01HL099773 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI THOMSON, JAMES ALEXANDER · 2009 to 2015
$7.8M
Transplantation of MHC Homozygous Vascular Progenitors in PrimatesU01HL134655 · NHLBI · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · PI SLUKVIN, IGOR I. · 2016 to 2022
$7.7M
Cancer Biology in the ZebrafishR01CA103846 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 2003 to 2022
$7.5M
iPSC-based blood regenerative therapies for AIDSR01HL116221 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SLUKVIN, IGOR I., TORBETT, BRUCE EDWARD · 2013 to 2017
$3.4M
NCI NIH HHS P01 CA163222NCI NIH HHS R01 CA103846NHLBI NIH HHS P01 HL032262NHLBI NIH HHS P01 HL131477NHLBI NIH HHS U01 HL134655NHLBI NIH HHS U01 HL134812NIDDK NIH HHS R24 DK092760NIH HHS P51 OD011106NIH HHS P51 RR000167NIH HHS R01HL116221NIH HHS U01HL099773NIH HHS U01HL10001NIH HHS UO1 HL100395
6 · The paper itself

Abstract

NOTCH signaling is required for the arterial specification and formation of hematopoietic stem cells (HSCs) and lympho-myeloid progenitors in the embryonic aorta-gonad-mesonephros region and extraembryonic vasculature from a distinct lineage of vascular endothelial cells with hemogenic potential. However, the role of NOTCH signaling in hemogenic endothelium (HE) specification from human pluripotent stem cell (hPSC) has not been studied. Here, using a chemically defined hPSC differentiation system combined with the use of DLL1-Fc and DAPT to manipulate NOTCH, we discover that NOTCH activation in hPSC-derived immature HE progenitors leads to formation of CD144

Indexed as

HematopoiesisNeovascularization, PhysiologicSignal TransductionAnimalsAntigens, CDArteriesCalcium-Binding ProteinsCell DifferentiationCell LineCell LineageCell TrackingCoculture TechniquesEmbryo, MammalianEndothelium, VascularErythroid Precursor CellsHemangioblastsAntigens, CDCalcium-Binding ProteinsDLK1 protein, humanIntercellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, Notch

Identifiers

PMID29739946
PMCPMC5940870
OpenAlexW2800697685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.